Searched for
BIOCON PHARMA INC
ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till dateUS company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...- Biocon inaugurates first manufacturing facility in USBiocon Ltd has inaugurated its first US manufacturing facility in Cranbury, New Jersey, operated by its subsidiary, Biocon Generics Inc. Fo...
- Biocon plans $150-million capex in two yearsBiocon plans a $150 million capital expenditure, allocating $100 million to biologics, primarily enhancing Malaysian capacities, and $50 mi...
- Glenmark, Biocon units recall products in US: USFDAGlenmark and Biocon are recalling products in the U.S. due to manufacturing issues. Glenmark is recalling 8,160 bottles of chlorpromazine h...
- Q2 results this week: Airtel, Maruti Suzuki, L&T among 392 companies to announce earningsThe second quarter earnings season for India Inc. is expected to be muted, with possibly the slowest growth in over four years. Major compa...
- Stocks in news: IDFC First Bank, Kotak Mahindra Bank, IDBI Bank, Shaily Engineering, RVNLGMR Smart Electricity Distribution, a step down subsidiary of GMR Power and Urban Infra, has received a letter of award (LOA) from Purvanch...
- Biocon acquires Eywa Pharma's US-based plant for $7.7 millionBiocon Limited announced that its wholly-owned subsidiary, Biocon Generics Inc., has acquired Eywa Pharma Inc.’s oral solid dosage manufact...
- Q1 results this week: LIC, Adani Ports, IRCTC, Hero MotoCorp, Nykaa and othersAdani Ports, Coal India, Siemens, Hindalco, Linde India, Lloyds Metals, Phoenix Mills, Oil India, Prestige Estates, Aarti Industries, Happi...
- Viatris buys Taparias' eyecare business for Rs 2,460 croreThe ophthalmology portfolio consists of six new chemical entities (NCEs or molecules) that are under phase 3 trials and will be developed f...
- Stocks in the news: Wipro, RIL, Hindalco, HDFC, Tata Steel, Welspun Corp and BioconIT major Wipro will announce its fourth-quarter and FY20 results today.
- USFDA in active mode, issues obersvations to 4 drug makers in 3 days!SMS Pharma today informed exchanges that the United States Food and Drug Administration (USFDA) conducted a cGMP inspection at Kandivalasa,...
- Share market update: Nifty Pharma lone sectoral gainer; Aurobindo Pharma jumps 5%The Nifty Pharma index was trading 1.35 per cent up at 10,442.2 around 12:50 pm.
- Stock market update: Pharma stocks in good health; Divi's Labs, Lupin jump up to 3%The Nifty Pharma index was trading 0.97 per cent up at 10,047 around 10:30 am.
- Roche sues Biocon, Mylan, DCGI over breast cancer drugRoche has sued Mylan, Biocon for launching biosimilar version of the original breast cancer drug, Herceptin, and DCGI for allowing the laun...
- Biocon inks licensing pact with US-based Quark PharmaBiocon today said it has inked a pact with Quark Pharmaceuticals, Inc to develop a range of siRNA (small interfering RNA) based novel thera...
- Biocon-Mylan partnership has a potential of $33 billion from biosimilar drugsTwo years after announcing a JV with Mylan, Biocon has revealed the potential of its drugs under the biologics deal with Mylan.
- Pfizer scraps Insulin pact with BioconPfizer Inc has terminated a deal to sell Biocon's insulin products globally, dealing the Indian company a blow and calling into question si...
- Obama's tax worries pharma tooApart from IT, the domestic pharma industry is also worried over President Obama's proposal to end tax breaks for US companies, which are e...
- Biocon picks up 70% in German pharma co AxiCorp for e30 mnThe deal will enable the Bangalore-based player to market its injectible insulin, generics, biosimilars and biologics in Europe.
- India falls behind in patents raceIndia is fourth among developing countries in filing for international patents. South Korea occupies the top slot followed by China and Sou...
Load More
